Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-02-21
2006-02-21
Desai, Rita (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C514S277000
Reexamination Certificate
active
07002014
ABSTRACT:
The present invention relates to a process for controlling the crystal form of 3-pyridyl-1-hydroxy-ethylidene-1,1-bisphosphonic acid salt (Risedronate). The process employs a pH adjustment step to induce the proper hydrate form and thereby avoiding inadvertent nucleation of undesired hydrate forms.
REFERENCES:
patent: 5583122 (1996-12-01), Benedict et al.
patent: 5622721 (1997-04-01), Dansereau et al.
patent: 6410520 (2002-06-01), Cazer et al.
patent: 2002/0002282 (2002-01-01), Cazer et al.
patent: WO01/56983 (2001-08-01), None
Gossman, W.L. et al., “Three Hydrates of the Bisphosphonate Risedronate, Consisting of One Molecular and Two Ionic Structures”,Acta Crystallographica Section C. Crystal Structure Communication, 2003, pp. M33-M36, vol. 50, No. 2.
Nicbolbon et al., “A General Method of Preparation of Tetramethyl Alkyl-1-hydroy-1, 1-diphosphonates”,J. of Organic Chemistry, 1971, vol. 36, No. 24, pp. 3844-3845.
Ebetino et al, “Elucidation of Pharmacophore for the Bisphosphonate Mechanism of Bone Antiresorptive Activity”,Phosphorus, Sulfur, and Silicon, 1996, vols. 109-110, pp. 217-220.
Ebetino et al., “Recent Work on the Synthesis of Phosphonate-Containing, Bone-Active Heterocycles”,Heterocycles, 1990, vol., 30, No. 2, pp. 855-862.
Desai Rita
Echler Sr. Richard S.
The Procter & Gamble & Company
LandOfFree
Process for controlling crystal structure of risedronate does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for controlling crystal structure of risedronate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for controlling crystal structure of risedronate will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3635892